About Spiral Therapeutics
Spiral Therapeutics is a company based in Brisbane (United States) founded in 2016. Spiral Therapeutics has raised $47.2 million across 5 funding rounds from investors including Esperante, Catalio Capital Management and Humboldt Fund. Spiral Therapeutics offers products and services including SPT-2101 and MICS Platform. Spiral Therapeutics operates in a competitive market with competitors including Lyra Therapeutics, Decibel Therapeutics, Perceive Bio, Akouos and Auris Medical, among others.
- Headquarter Brisbane, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spiral Therapeutics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$47.2 M (USD)
in 5 rounds
-
Latest Funding Round
$27 M (USD), Series B
Apr 14, 2026
-
Investors
Esperante
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spiral Therapeutics
Spiral Therapeutics offers a comprehensive portfolio of products and services, including SPT-2101 and MICS Platform.
Sustained-release steroid for treating Ménière’s disease effectively.
Minimally invasive system for precise and durable drug exposure in the ear.
People of Spiral Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of Spiral Therapeutics
Spiral Therapeutics has successfully raised a total of $47.2M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $27 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Spiral Therapeutics
Spiral Therapeutics has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Esperante, Catalio Capital Management and Humboldt Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Esperante is focused on innovative life science investments.
|
Locked | Locked | Locked | |
|
Venture capital is provided to biomedical technology startups.
|
Locked | Locked | Locked | |
|
Early-stage companies in science and technology are supported by Humboldt Fund.
|
Locked | Locked | Locked |
Investor details for Spiral Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spiral Therapeutics
Investment portfolio details for Spiral Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spiral Therapeutics
Detailed financials for Spiral Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spiral Therapeutics Comparisons
Peer comparison for Spiral Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spiral Therapeutics
Spiral Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lyra Therapeutics, Decibel Therapeutics, Perceive Bio, Akouos and Auris Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Medicines are developed to protect, repair, and restore hearing capacity.
|
|
| Locked | Locked | Locked |
Developer of therapeutics to treat diabetes and eye diseases
|
|
| Locked | Locked | Locked |
Developer of gene therapies to restore and preserve hearing capabilities in genetically defined populations
|
|
| Locked | Locked | Locked |
Speciality Pharma company developing novel therapies for inner ear disorders
|
Detailed competitors of Spiral Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spiral Therapeutics
Complete news archive for Spiral Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spiral Therapeutics
Spiral Therapeutics was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Spiral Therapeutics is headquartered in Brisbane, United States. It is registered at Brisbane, California, United States.
Spiral Therapeutics is a funded company, having raised a total of $47.2M across 5 funding rounds to date.
Spiral Therapeutics was founded in 2016 and is headquartered in Brisbane, United States. Therapeutics targeting balance disorders and hearing loss are developed by the company within the biotechnology sector. A pipeline is advanced, with the lead program SPT-2101 consisting of a sustained-release steroid formulation for Ménières disease treatment. Operations focus on inner ear conditions through pharmaceutical innovation.
Spiral Therapeutics's top competitors include Decibel Therapeutics, Lyra Therapeutics and Akouos.
Spiral Therapeutics offers SPT-2101 and MICS Platform.
Spiral Therapeutics has 8 investors. Key investors include Esperante, Catalio Capital Management, Humboldt Fund, Prévigesst, and Sunghwan Choi.